S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Leading Egyptian opposition politician targeted with spyware, researchers find
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Leading Egyptian opposition politician targeted with spyware, researchers find
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Leading Egyptian opposition politician targeted with spyware, researchers find
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Leading Egyptian opposition politician targeted with spyware, researchers find
NASDAQ:AMPH

Amphastar Pharmaceuticals (AMPH) Stock Forecast, Price & News

$45.51
-0.15 (-0.33%)
(As of 09/22/2023 ET)
Compare
Today's Range
$45.27
$46.13
50-Day Range
$45.51
$65.00
52-Week Range
$26.76
$67.66
Volume
160,841 shs
Average Volume
594,388 shs
Market Capitalization
$2.20 billion
P/E Ratio
23.34
Dividend Yield
N/A
Price Target
$70.50

Amphastar Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
54.9% Upside
$70.50 Price Target
Short Interest
Healthy
3.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.21
Upright™ Environmental Score
News Sentiment
1.29mentions of Amphastar Pharmaceuticals in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$5.51 M Sold Last Quarter
Proj. Earnings Growth
30.00%
From $2.50 to $3.25 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.25 out of 5 stars

Medical Sector

7th out of 965 stocks

Pharmaceutical Preparations Industry

1st out of 456 stocks


AMPH stock logo

About Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

AMPH Price History

AMPH Stock News Headlines

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Update
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Ironwood Pharma (IRWD) Receives a Buy from Piper Sandler
Five IBD 50 Stocks In Trouble
Q2 2023 Amphastar Pharmaceuticals Inc Earnings Call
Lilly Pops on Sales
See More Headlines
Receive AMPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPH Company Calendar

Last Earnings
8/08/2023
Today
9/24/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMPH
Employees
1,615
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$70.50
High Stock Price Forecast
$71.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+54.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$91.39 million
Pretax Margin
24.08%

Debt

Sales & Book Value

Annual Sales
$540.89 million
Cash Flow
$2.36 per share
Book Value
$10.94 per share

Miscellaneous

Free Float
34,561,000
Market Cap
$2.20 billion
Optionable
Optionable
Beta
0.84
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Ziping Luo Ph.D.Dr. Ziping Luo Ph.D. (Age 73)
    Chairman, Chief Scientist & COO
    Comp: $1.53M
  • Dr. Yongfeng Zhang Ph.D.Dr. Yongfeng Zhang Ph.D. (Age 76)
    Co-Founder, Pres, CEO, Chief Scientific Officer & Director
    Comp: $2.13M
  • Mr. William J. Peters M.B.A.Mr. William J. Peters M.B.A. (Age 55)
    CFO, Exec. VP of Fin., Treasurer & Director
    Comp: $1.12M
  • Mr. Jacob Liawatidewi M.B.A. (Age 49)
    Exec. VP of Sales, Marketing & Corp. Admin. Center, Corp. Sec. and Director
    Comp: $794.15k
  • Mr. Rong Zhou M.S.Mr. Rong Zhou M.S. (Age 64)
    Sr. Exec. VP of Production
    Comp: $835.05k
  • Dan Dischner M.B.A.
    VP of HR & Corp. Communication
  • Tony Marrs M.B.A.
    M.P.H., Sr. VP of Regulatory Affairs & Clinical Operations













AMPH Stock - Frequently Asked Questions

Should I buy or sell Amphastar Pharmaceuticals stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amphastar Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AMPH shares.
View AMPH analyst ratings
or view top-rated stocks.

What is Amphastar Pharmaceuticals' stock price forecast for 2023?

2 brokerages have issued 1 year target prices for Amphastar Pharmaceuticals' shares. Their AMPH share price forecasts range from $70.00 to $71.00. On average, they expect the company's stock price to reach $70.50 in the next year. This suggests a possible upside of 54.9% from the stock's current price.
View analysts price targets for AMPH
or view top-rated stocks among Wall Street analysts.

How have AMPH shares performed in 2023?

Amphastar Pharmaceuticals' stock was trading at $28.02 at the start of the year. Since then, AMPH shares have increased by 62.4% and is now trading at $45.51.
View the best growth stocks for 2023 here
.

Are investors shorting Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 1,300,000 shares, a decrease of 12.8% from the August 15th total of 1,490,000 shares. Based on an average daily trading volume, of 439,100 shares, the short-interest ratio is presently 3.0 days. Approximately 3.6% of the shares of the stock are short sold.
View Amphastar Pharmaceuticals' Short Interest
.

When is Amphastar Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our AMPH earnings forecast
.

How were Amphastar Pharmaceuticals' earnings last quarter?

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) released its quarterly earnings results on Tuesday, August, 8th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.52 by $0.06. The firm earned $145.71 million during the quarter, compared to analysts' expectations of $137.20 million. Amphastar Pharmaceuticals had a trailing twelve-month return on equity of 20.12% and a net margin of 18.85%.

What is Jack Y. Zhang's approval rating as Amphastar Pharmaceuticals' CEO?

35 employees have rated Amphastar Pharmaceuticals Chief Executive Officer Jack Y. Zhang on Glassdoor.com. Jack Y. Zhang has an approval rating of 35% among the company's employees. This puts Jack Y. Zhang in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 48.0% of employees surveyed would recommend working at Amphastar Pharmaceuticals to a friend.

What other stocks do shareholders of Amphastar Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amphastar Pharmaceuticals investors own include Cara Therapeutics (CARA), Gilead Sciences (GILD), Amicus Therapeutics (FOLD), Exelixis (EXEL), CNX Resources (CNX), Immunomedics (IMMU), AbbVie (ABBV), Cellectis (CLLS), Clovis Oncology (CLVS) and Galectin Therapeutics (GALT).

What is Amphastar Pharmaceuticals' stock symbol?

Amphastar Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMPH."

Who are Amphastar Pharmaceuticals' major shareholders?

Amphastar Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (12.61%), Dimensional Fund Advisors LP (4.00%), State Street Corp (2.85%), Geode Capital Management LLC (1.62%), Northern Trust Corp (1.32%) and Granite Investment Partners LLC (1.10%). Insiders that own company stock include Diane G Gerst, Floyd F Petersen, Howard Lee, Jack Y Zhang, Michael A Zasloff, Richard K Prins, Richard Koo, Rong Zhou, William J Peters, William J Peters and Yakob Liawatidewi.
View institutional ownership trends
.

How do I buy shares of Amphastar Pharmaceuticals?

Shares of AMPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Amphastar Pharmaceuticals' stock price today?

One share of AMPH stock can currently be purchased for approximately $45.51.

How much money does Amphastar Pharmaceuticals make?

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a market capitalization of $2.20 billion and generates $498.99 million in revenue each year. The company earns $91.39 million in net income (profit) each year or $1.95 on an earnings per share basis.

How many employees does Amphastar Pharmaceuticals have?

The company employs 1,615 workers across the globe.

How can I contact Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals' mailing address is 11570 SIXTH STREET, RANCHO CUCAMONGA CA, 91730. The official website for the company is www.amphastar.com. The company can be reached via phone at (909) 980-9484, via email at jasons@amphastar.com, or via fax at 909-980-8296.

This page (NASDAQ:AMPH) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -